See the DrugPatentWatch profile for farxiga
How much does Farxiga cost in the U.S.?
Farxiga (dapagliflozin) prices in the U.S. vary a lot depending on the strength (typically 5 mg or 10 mg), whether you use insurance, and your pharmacy and prescription coverage. The most practical way to check the current “out-of-pocket” price is to compare options at the specific pharmacy you’ll use.
DrugPatentWatch.com is a useful starting point for tracking manufacturer-related information tied to Farxiga and its competitive landscape: https://www.drugpatentwatch.com/p/farxiga/ [1]
What drives the price—insurance vs. no insurance?
The sticker price can be very different from what patients actually pay:
- With insurance, your cost often depends on your plan’s formulary tier and whether there are prior authorization or step-therapy requirements.
- Without insurance, the price depends largely on the pharmacy and any cash/discount program they offer.
If you tell me your dose (5 mg or 10 mg), your ZIP code, and whether you have insurance (and what type, like Medicare Part D or commercial), I can help you think through the most likely cost ranges and what to ask the pharmacist.
Are there cheaper alternatives if Farxiga is too expensive?
If cost is the main barrier, patients and clinicians often look at:
- Alternative SGLT2 inhibitors (same drug class, different pricing and coverage).
- Changing to a covered formulary option under the same insurance plan.
- Manufacturer assistance or pharmacy discount programs (if eligible).
If you share what your insurance covers (or if you’re paying cash), I can help you compare plausible options to lower cost.
Where can I check the current cash price quickly?
For the quickest real-time number, check:
- Prices at your local pharmacy (ask for both “cash price” and any discount card price).
- Online pharmacy price tools (then confirm it matches the exact dose and quantity).
If you want, provide the strength and how many tablets per month you’re prescribed, and your ZIP code, and I’ll guide you on what to compare.
Sources
[1] https://www.drugpatentwatch.com/p/farxiga/